RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tamaro Hudson to Trypsin Inhibitor, Kazal Pancreatic

Back to Details
This is a "connection" page, showing publications Tamaro Hudson has written about Trypsin Inhibitor, Kazal Pancreatic.
Tamaro Hudson
Connection Strength
0.641
Trypsin Inhibitor, Kazal Pancreatic
  1. Beyene DA, Naab TJ, Kanarek NF, Apprey V, Esnakula A, Khan FA, Blackman MR, Brown CA, Hudson TS. Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men. Prostate. 2018 08; 78(11):801-811.
    View in: PubMed
    Score: 0.641
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support